Documentation

Cancers are as common in people with intellectual disabilities as in the general population but differ in several aspects. Oncodefi's bibliographic watch centralises specialised documentation for better knowledge.

Oncodefi synthesizes numerous articles in order to make the information accessible to all.

On the basis of more than a thousand articles on cancer and intellectual disability, accumulated for more than 20 years, the synthesis of data will be progressively put online on the dedicated website www.oncodefi.net

It will provide information on the frequency and distribution of cancers and their therapeutic management, taking into account the specificities of the different conditions.

Oncodefi conducts research, the results of which are published in numerous articles and reviews.

Books & Book Chapters

Publications écrites

Oncodefi.net

A bibliographic watch is carried out on the oncodefi.net website for health professionals. This site centralizes all the worldwide articles dealing with cancer and intellectual disability.

Oncodefi.net is the second website of the association that gathers many scientific articles on cancer and intellectual disability. It aims to become a reference site in these fields so that the medical profession can have access to all these articles in a single site. The site is regularly updated with new content thanks to the bibliographic watch carried out. Numerous cancers and different intellectual disabilities are listed.

Director

Dr Daniel satgé

nitiator of the project

Anatomical pathologist, director of the association Oncodéfi, Monptellier.

Clinical Study Technician

Louisa Allouche

Help the association Oncodéfi

All donations are important, big or small, and will improve the treatment of cancer in people with intellectual disabilities.

Journées nationales Oncodéfi

21-22 Octobre 2021 à Montpellier

Organisées par l’association Oncodéfi, en lien avec le Centre de Lutte contre le Cancer ICM Val d’Aurelle de Montpellier. Elles font suite au grand intérêt porté aux cancers chez les personnes déficientes intellectuelles lors du dernier symposium international en 2018.